Jacks Lee retired from the Board of Directors effective June 17, 2026, and transitioned to a consulting role focused on global strategic supply and manufacturing operations. Moncef Slaoui was appointed as a Class II director, effective immediately, with a term expiring in 2028. Vaxcyte, Inc. is a biotechnology company developing vaccine candidates.
